Patent: 11,278,615
Summary for Patent: 11,278,615
| Title: | Mixed allergen compositions and methods for using the same |
| Abstract: | Mixed allergen compositions of two or more different allergens are provided. In some instances, the mixed allergen compositions include: a nut allergen; an animal allergen; and at least one of: a non-nut plant allergen; a biotic agent; and a vitamin. Also provided are methods of administering the mixed allergen compositions to a subject. The mixed allergen compositions find use in a variety of applications, including health maintenance, immune balance, gut balance, immune support, health improvement and therapeutic applications. |
| Inventor(s): | Kari C. Nadeau |
| Assignee: | Leland Stanford Junior University |
| Application Number: | US17/239,252 |
| Patent Claims: | see list of patent claims |
Details for Patent 11,278,615
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Modernatx, Inc. | SPIKEVAX | covid-19 vaccine, mrna | Injection | 125752 | January 31, 2022 | ⤷ Start Trial | 2041-04-23 |
| Modernatx, Inc. | SPIKEVAX | covid-19 vaccine, mrna | Injection | 125752 | September 11, 2023 | ⤷ Start Trial | 2041-04-23 |
| Modernatx, Inc. | SPIKEVAX | covid-19 vaccine, mrna | Injection | 125752 | July 9, 2025 | ⤷ Start Trial | 2041-04-23 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 11,278,615
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2016219793 | ⤷ Start Trial |
| Australia | 2022201699 | ⤷ Start Trial |
| Brazil | 112017017894 | ⤷ Start Trial |
| Canada | 2977127 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
